Hap Trading, LLC Precigen, Inc. Call Options Transaction History

Hap Trading, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$1.27 - $2.26 $6,223 - $11,073	-4,900 Reduced 24.87%	14,800 $1,000
Q3 2022 Nov 14, 2022	BUY	$1.41 - $2.79 $5,217 - $10,323	3,700 Added 23.13%	19,700 $2,000
Q2 2022 Aug 12, 2022	BUY	$1.15 - $2.53 $1,839 - $4,047	1,600 Added 11.11%	16,000 $2,000
Q1 2022 May 12, 2022	SELL	$1.91 - $3.98 $17,572 - $36,616	-9,200 Reduced 38.98%	14,400 $2,000
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $27,534 - $42,900	7,800 Added 49.37%	23,600 $6,000
Q3 2021 Nov 10, 2021	SELL	$4.99 - $6.55 $30,938 - $40,610	-6,200 Reduced 28.18%	15,800 $7,000
Q2 2021 Aug 11, 2021	BUY	$6.24 - $8.22 $49,296 - $64,938	7,900 Added 56.03%	22,000 $12,000
Q1 2021 May 14, 2021	SELL	$6.74 - $10.95 $300,604 - $488,369	-44,600 Reduced 75.98%	14,100 $10,000
Q4 2020 Feb 16, 2021	BUY	$3.75 - $10.56 $90,750 - $255,552	24,200 Added 70.14%	58,700 $164,000
Q3 2020 Nov 13, 2020	BUY	$3.5 - $6.2 $29,050 - $51,460	8,300 Added 31.68%	34,500 $20,000
Q2 2020 Aug 10, 2020	BUY	$2.16 - $5.46 $25,488 - $64,428	11,800 Added 81.94%	26,200 $17,000
Q1 2020 May 08, 2020	BUY	$1.46 - $7.19 $21,024 - $103,536	14,400 New	14,400 $13,000

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $156M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.